3G5E image
Entry Detail
PDB ID:
3G5E
Keywords:
OXIDOREDUCTASE
Title:
Human aldose reductase complexed with IDD 740 inhibitor
Biological Source:
Source Organism:
Homo sapiens
Host Organism:
Escherichia coli
PDB Version:
Deposition Date:
2009-02-05
Release Date:
2009-03-24
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
1.80 Å
R-Value Free:
0.18
R-Value Work:
0.14
R-Value Observed:
0.14
Space Group:
P 1 21 1
3G5E validation report
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Description:Aldose reductase
Chain IDs:A
Chain Length:319
Number of Molecules:1
Biological Source:Homo sapiens
UniProt ID:P15121 Pfam ID:PF00248 EC:1.1.1.188
Ligand Molecules
NDP
Q74
Primary Citation
Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.
Bioorg.Med.Chem.Lett. 19 2006 2008 (2009)
PMID: 19250825 DOI: 10.1016/j.bmcl.2009.02.037

Abstact

Efforts to identify treatments for chronic diabetic complications have resulted in the discovery of a novel series of highly potent and selective [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acid aldose reductase inhibitors. The lead candidate, [6-methyl-3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acid example 16, inhibits aldose reductase with an IC50 of 8 nM, while being inactive against aldehyde reductase (IC50>100 microM), a related enzyme involved in the detoxification of reactive aldehydes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
1Z3N